IBDEI0BB ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4961,2)
 ;;=^271896
 ;;^UTILITY(U,$J,358.3,4962,0)
 ;;=682.2^^25^259^10
 ;;^UTILITY(U,$J,358.3,4962,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4962,1,2,0)
 ;;=2^682.2
 ;;^UTILITY(U,$J,358.3,4962,1,5,0)
 ;;=5^Cellulitis trunk
 ;;^UTILITY(U,$J,358.3,4962,2)
 ;;=^271890
 ;;^UTILITY(U,$J,358.3,4963,0)
 ;;=682.9^^25^259^1
 ;;^UTILITY(U,$J,358.3,4963,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4963,1,2,0)
 ;;=2^682.9
 ;;^UTILITY(U,$J,358.3,4963,1,5,0)
 ;;=5^Cellulitis NOS
 ;;^UTILITY(U,$J,358.3,4963,2)
 ;;=^21160
 ;;^UTILITY(U,$J,358.3,4964,0)
 ;;=691.8^^25^260^4
 ;;^UTILITY(U,$J,358.3,4964,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4964,1,2,0)
 ;;=2^691.8
 ;;^UTILITY(U,$J,358.3,4964,1,5,0)
 ;;=5^Atopic Dermatitis
 ;;^UTILITY(U,$J,358.3,4964,2)
 ;;=^87342
 ;;^UTILITY(U,$J,358.3,4965,0)
 ;;=692.70^^25^260^1
 ;;^UTILITY(U,$J,358.3,4965,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4965,1,2,0)
 ;;=2^692.70
 ;;^UTILITY(U,$J,358.3,4965,1,5,0)
 ;;=5^Actinic Dermatitis
 ;;^UTILITY(U,$J,358.3,4965,2)
 ;;=^271910
 ;;^UTILITY(U,$J,358.3,4966,0)
 ;;=692.9^^25^260^3
 ;;^UTILITY(U,$J,358.3,4966,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4966,1,2,0)
 ;;=2^692.9
 ;;^UTILITY(U,$J,358.3,4966,1,5,0)
 ;;=5^Allergic Dermatitis
 ;;^UTILITY(U,$J,358.3,4966,2)
 ;;=^27800
 ;;^UTILITY(U,$J,358.3,4967,0)
 ;;=373.31^^25^260^10
 ;;^UTILITY(U,$J,358.3,4967,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4967,1,2,0)
 ;;=2^373.31
 ;;^UTILITY(U,$J,358.3,4967,1,5,0)
 ;;=5^Eyelid Dermatitis
 ;;^UTILITY(U,$J,358.3,4967,2)
 ;;=Eyelid Dermatitis^269060
 ;;^UTILITY(U,$J,358.3,4968,0)
 ;;=694.0^^25^260^12
 ;;^UTILITY(U,$J,358.3,4968,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4968,1,2,0)
 ;;=2^694.0
 ;;^UTILITY(U,$J,358.3,4968,1,5,0)
 ;;=5^Herpetiformis Dermatitis
 ;;^UTILITY(U,$J,358.3,4968,2)
 ;;=^33052
 ;;^UTILITY(U,$J,358.3,4969,0)
 ;;=698.4^^25^260^16
 ;;^UTILITY(U,$J,358.3,4969,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4969,1,2,0)
 ;;=2^698.4
 ;;^UTILITY(U,$J,358.3,4969,1,5,0)
 ;;=5^Psychogenic Dermatitis
 ;;^UTILITY(U,$J,358.3,4969,2)
 ;;=Psychogenic Dermatitis^186786
 ;;^UTILITY(U,$J,358.3,4970,0)
 ;;=698.3^^25^260^13
 ;;^UTILITY(U,$J,358.3,4970,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4970,1,2,0)
 ;;=2^698.3
 ;;^UTILITY(U,$J,358.3,4970,1,5,0)
 ;;=5^Neuro Dermatitis
 ;;^UTILITY(U,$J,358.3,4970,2)
 ;;=^70705
 ;;^UTILITY(U,$J,358.3,4971,0)
 ;;=695.3^^25^260^17
 ;;^UTILITY(U,$J,358.3,4971,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4971,1,2,0)
 ;;=2^695.3
 ;;^UTILITY(U,$J,358.3,4971,1,5,0)
 ;;=5^Rosacea, Keratitis
 ;;^UTILITY(U,$J,358.3,4971,2)
 ;;=^107114^370.49
 ;;^UTILITY(U,$J,358.3,4972,0)
 ;;=690.10^^25^260^18
 ;;^UTILITY(U,$J,358.3,4972,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4972,1,2,0)
 ;;=2^690.10
 ;;^UTILITY(U,$J,358.3,4972,1,5,0)
 ;;=5^Seborrheic Dermatitis
 ;;^UTILITY(U,$J,358.3,4972,2)
 ;;=^188703
 ;;^UTILITY(U,$J,358.3,4973,0)
 ;;=692.81^^25^260^6
 ;;^UTILITY(U,$J,358.3,4973,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4973,1,2,0)
 ;;=2^692.81
 ;;^UTILITY(U,$J,358.3,4973,1,5,0)
 ;;=5^Deodorant Dermatitis
 ;;^UTILITY(U,$J,358.3,4973,2)
 ;;=^271911
 ;;^UTILITY(U,$J,358.3,4974,0)
 ;;=693.0^^25^260^9
 ;;^UTILITY(U,$J,358.3,4974,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4974,1,2,0)
 ;;=2^693.0
 ;;^UTILITY(U,$J,358.3,4974,1,5,0)
 ;;=5^Drug Dermatitis(Internal, Taken Appropriately)
 ;;^UTILITY(U,$J,358.3,4974,2)
 ;;=^33042
 ;;^UTILITY(U,$J,358.3,4975,0)
 ;;=692.3^^25^260^8
 ;;^UTILITY(U,$J,358.3,4975,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4975,1,2,0)
 ;;=2^692.3
 ;;^UTILITY(U,$J,358.3,4975,1,5,0)
 ;;=5^Drug Dermatitis(External)
 ;;
 ;;$END ROU IBDEI0BB
